Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It was Printed in the Bullet Points of the 8/25 Call as well as verbally conveyed by BIEL's VP of Sales
<<<<<<< "The agreement between Biel and Synergy Corp. STATES 975,000 devices will be purchased and distributed in 25 countries?" Where is this "STATED?" >>>>>>>
Synergy will purchase 975,000 RecoveryRx units over the first 18 months.
This is a minimum number of units. IMO, could end up being more than 975,000 .
KN on Linkedin yesterday, "Our OEM plan is clicking as we have added 25 new countries, SEA, APAC, CIS, Africa, MENA. Disruptive technology providing pain relief w/no interactions, lowering oral meds by 50+ percent"
https://www.linkedin.com/feed/update/urn:li:activity:6970397429175050241/
Yep pinhigh, 1.9 Billion Women of Reproductive Age Worldwide
Allay, non-drug Menstrual Pain Relief.
Yes, $7 a bottle sounds great until the 'Side Effects Bill' comes due
<<<<<<<<<< Tylenol is affordable.>>>>>>>>>>
Tylenol Side Effects:
nausea
vomiting
loss of appetite
sweating
extreme tiredness
unusual bleeding or bruising
pain in the upper right part of the stomach
yellowing of the skin or eyes
flu-like symptoms
red, peeling or blistering skin
rash
hives
itching
swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
hoarseness
difficulty breathing or swallowing
About 1,600 U.S. cases of acute liver failure occur each year due to acetaminophen overuse. And some 500 people die each year from overdosing on the drug.
Yep JGD, people need to think in dollars not number of shares
Is ENDV better off than BIEL because they did 2 Reverse Splits, the most recent one a 1 for 1,000 RS, and now have 1.5 million Shares Outstanding rather than billions?
The answer is no, BIEL's Market Cap is still over 17x higher than ENDV's,
$1.133 million for ENDV vs $19.76 million for BIEL.
Maralko BIEL's Greece Distributor has "Neo" Allay
http://actipatch.elitehost.gr/%CF%80%CF%81%CE%BF%CF%8A%CF%8C%CE%BD/allay-%CE%B3%CE%B9%CE%B1-%CF%84%CE%BF%CF%85%CF%82-%CF%80%CF%8C%CE%BD%CE%BF%CF%85%CF%82-%CF%84%CE%B7%CF%82-%CF%80%CE%B5%CF%81%CE%B9%CF%8C%CE%B4%CE%BF%CF%85/
Allay for period pains Indicative application of Allay
Allay for period pains
€27.90 (with VAT)
Extremely thin and light. Comfortable and discreet. For 10+ menstrual cycles. Immediate therapeutic effect. No drugs.
Allay proves to be particularly effective for period pains and is superior to pharmaceutical preparations. The simple application and lack of side effects make it the treatment of choice. You can use this product for more than 10 cycles. It offers 720 hours of continuous operation (on-off switch), is particularly thin, light, comfortable and discreet, does not contain drugs, is safe and the therapeutic effect appears immediately.
Go BIEL!!!
Advertising in medical publications is probably the best vehicle for commercial RecoveryRx promotion but that takes an advertising budget
BIEL made serious cuts in their budget to avoid further dilution.
Right now the JIS/OrthoAlliance will get the Recovery Word out to 62 Orthopedic Surgeons with zero advertising expense through Dr. Berend. And this will be a personal, 'this is what we found', recommendation from a colleague not a page in a magazine.
JIS Orthopedics was acquired in 1/2022 by the OrthoAlliance
The OrthoAlliance has 25 facilities and 70 doctors.
Dr Keith Berend, who has been with JIS for 9 years, is now the Chief Medical Development Officer at OrthoAlliance.
The JIS use of RecoveryRx will now be shared with 62 other Orthopedic Surgeons.
https://joinorthoalliance.com/#s6
https://www.jointimplantsurgeons.com/physicians/dr-keith-berend
Yes "Not Ordered", Orders can be Cancelled
The 975,000 devices over the first 18 months is a stipulation in the Distribution Contract.
A Contract signed by both parties has much more legal weight than a purchase order.
Uhhh, hate to break it to ya, BIEL Up 12.5 %, closed at .0009 Today
<<<<<<<<<<< Still at 0.0008 >>>>>>>>>>
Buys = 5.2 million shares
Sells = 1.2 million shares
Stick around until the Closing Bell tomorrow.
JIS is not going to promote RecoveryRx like a Distributor would
They have posters hung in their offices that show that RecoveryRx is part of their 6 step "JIS Recovery Pathway", "Optimizing your surgical recovery one step at a time".
This 6 Step Recovery Pathway is most likely in brochures that JIS hands out to potential customers also.
This sets JIS apart from the traditional drug based solution to pain that other Orthopedic Surgeons would use.
Yep InvestinBIEL, and it gets even better ,,,,,,,
JIS Orthopedics was acquired in 1/2022 by the OrthoAlliance
The OrthoAlliance has 25 facilities and 70 doctors.
Dr Keith Berend, who has been with JIS for 9 years, is now the Chief Medical Development Officer at OrthoAlliance.
The JIS use of RecoveryRx will now be shared with 62 other Orthopedic Surgeons.
https://joinorthoalliance.com/#s6
https://www.jointimplantsurgeons.com/physicians/dr-keith-berend
Thanks for the info bobby, I don't have any contacts but I would do a reply to Keith's Twitter with your experience.
Keith Nalepka @keith_nalepka "Pain Control"
·
20m
Working with one of the largest ortho clinics in Ohio/country using RRX post-op, poster size!!! The recommendations continue to grow! #pain #optimalrecovery get it?
JIS Orthopedics
50 years
70,000 Procedures
https://twitter.com/keith_nalepka
https://www.jointimplantsurgeons.com/
OTCQB, the step up from 'Pink Current' requires a one cent Share Price to be maintained
When the BIEL SP reaches .01 they will consider the upgrade to the OTCQB level.
The Synergy Deal was announced by a BIEL Corporate Officer. If you have proof that there is no Deal you should alert the SEC. If this is just an Opinion then it has little value.
Those that read the 11/2020 CE Mark PR know that it included OTC Sales for RecoveryRx
Along with all EU members many countries in MENA and ASEAN rely on the CE Mark for their Medical Device Approvals. So, no Doctor's prescription needed for RecoveryRx in dozens of countries.
Opens the Sales Market for 33+ Additional Countries
FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices.
The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain. These wearable devices can now be sold over the counter in 33 European Union (EU) countries, and many other non-EU countries like Australia that recognize the CE mark.
Must have missed post 297293
Post# 297293 of 297325 Saturday, August 27, 2022 12:44:31 PM
Minimum Purchase Commitments
Thompson Reuters Practical Law
Minimum Purchase Commitments
The parties should determine if the distributor will have a minimum purchase or order commitment. If so, the distribution agreement should include terms that specify:
How the minimum purchase or order commitment will be measured (for example, see Standard Document, Distribution Agreement (Pro-Seller): Section 8.06).
The seller's remedies for the distributor's failure to meet its minimum purchase or order commitment (for example, the right to terminate the agreement or receive liquidated damages).
https://uk.practicallaw.thomsonreuters.com/w-004-7296?contextData=(sc.Default)&transitionType=Default&firstPage=true
Your math is a wee bit off
$100 million divided by 975,000 devices = over $100 per device
Some medical institutions may charge patients close to $100 for the RecoveryRx but no distributor is going to pay anywhere near that amount and that is before the volume discount Synergy must have received for that large of an 18 month minimum.
Minimum Purchase Commitments
Thompson Reuters Practical Law
Minimum Purchase Commitments
The parties should determine if the distributor will have a minimum purchase or order commitment. If so, the distribution agreement should include terms that specify:
How the minimum purchase or order commitment will be measured (for example, see Standard Document, Distribution Agreement (Pro-Seller): Section 8.06).
The seller's remedies for the distributor's failure to meet its minimum purchase or order commitment (for example, the right to terminate the agreement or receive liquidated damages).
https://uk.practicallaw.thomsonreuters.com/w-004-7296?contextData=(sc.Default)&transitionType=Default&firstPage=true
Please provide evidence of another BIEL Distributor Agreement that specified a specific number of BIEL devices to be purchased in a specific amount of time.
We have the VP of Sales & member of the BOD stating in a conference call:
Signed Agreement
975,000 RecoveryRx Units
25 Countries
First 18 months
It is a Distribution Contract for 25 countries with a requirement written in the contract for a minimum of 975,000 RecoveryRx devices to be purchased in the first 18 months.
Contracts are legally binding agreements and if one party violates the terms laid out the party harmed by the violation is owed compensation.
If, "Synergy can buy as many or as few as they please", there would be no need for specifying 975,000 devices in the first 18 months.
This is not a 'Goal' for Synergy it is a specific quantity and time period written into the agreement.
Yesterday it was COGS, but that did not stick to the wall
<<<<<< After the COGS, the other expenses should be minimized as much as possible >>>>>
Still not acknowledging that BIEL has already cut spending extensively. KW has done a great job in making hard decisions to reduce expenses. Unfortunately that involved losing some good people, Sree and Kiki. Cut a business back too far and customer service suffers, customers start leaving.
Year ... Sales .........Net Loss ...........Total General/Admin expense
2012 - $500k ........ $2.412 million .............. $2.181 million
2013 - $665k ........ $2.168 million .............. $2.198 million
2014 - $1.289 mil . $2.677 million .............. $2.168 million
2015 - $2.339 mil . $2.469 million .............. $3.128 million
2016 - $2.089 mil . $2.106 million .............. $2.658 million
2017 - $1.763 mil . $2.118 million .............. $2.358 million
2018 - $1.045 mil . $2.988 million .............. $2.393 million
2019 - $941k ........ $2.325 million .............. $1.860 million
2020 - $829k ........ $1.159 million .............. $1.553 million
2021 - $1.609 mil . $289k ........................... $949k
Must be posting on the wrong Board
BIEL's CEO has not taken a salary since she took the CEO position 3 years ago.
She has also, along with St John's, forgone interest on BIEL debt totaling over $2 million.
A strong show of commitment to keeping BIEL in business without further dilution as it moves toward profitability.
There is a Global Chip Shortage Still Going On and we are basing performance on COGS?
It was worse in 2021, if you want to make a product that is based on Chips you are either going to pay 2x or 3x as much for the Chips or shut down your business.
The undeniable Fact here is that for 8 of the last 10 years BIEL had a Net Loss of over $2 million per year.
In 2020 BIEL had a NL of $1.159 million as they were starting the OEM transition.
In 2021, their first full year under OEM, BIEL had a NL of $289k on 1.6 million in Revenue.
<<<<<<<<<< expenses should be minimized as much as possible >>>>>>>>>>
Expenses have been minimized. Did you not listen to KN state that BIEL now operates with 7 employees?
Have you compared 2021 Sales/TGA/Net Loss to previous years?
<<<<<<< the trick is to minimize the expenses so far they have not been able to do that! >>>>>> Wrong
Year ... Sales .........Net Loss ...........Total General/Admin expense
2012 - $500k ........ $2.412 million .............. $2.181 million
2013 - $665k ........ $2.168 million .............. $2.198 million
2014 - $1.289 mil . $2.677 million .............. $2.168 million
2015 - $2.339 mil . $2.469 million .............. $3.128 million
2016 - $2.089 mil . $2.106 million .............. $2.658 million
2017 - $1.763 mil . $2.118 million .............. $2.358 million
2018 - $1.045 mil . $2.988 million .............. $2.393 million
2019 - $941k ........ $2.325 million .............. $1.860 million
2020 - $829k ........ $1.159 million .............. $1.553 million
2021 - $1.609 mil . $289k ........................... $949k
2021 had the lowest TGA and Net Loss in the last 10 years. The OEM business plan significantly lowered costs while producing the 4th highest revenue in BIEL's history..
Actually we should see that 975,000 be heavy on the front end as Synergy needs to fill up an empty supply chain stretching across 25 countries.
And the 975,000 is an 18 month minimum written into the contract. Synergy could always sell more.
<<<<<<<<<<<< That's 54,000 per month. IMPRESSIVE. >>>>>>>>>>>>>>
Thanks Hawk, Great turnaround time by KN to a shareholder request
3,000 units in 25 cases = 120 units per case.
3,000 units to a distributor so estimate between $10-12 per unit which adds $30k-36k to Q3 revenue.
The bullet points of the meeting stated that the signed agreement with Synergy Corp require them to purchase 975,000 RecoveryRx devices over the next 18 months. No dollar amount was stated.
RecoveryRx commands a higher price than ActiPatch as it is marketed as a medical professional device.
BIEL Feels Extra Strength RecoveryRx May Not Need a New 510k
ES RecoveryRx gains its strength from a new antenna configuration which focuses the RF signal more directly on the wound.
The electronics/battery stay the same.
If the FDA agrees that no new 510k is needed the ES RecoveryRx could be in production much quicker.
BIEL's Newest Partner, Synergy Corporation
Signed Agreement requires 975,000 RecoveryRx units in the first 18 months.
RecoveryRx Sales in SEA, APAC, Africa, MENA.
https://synergy-corporation.com/our-business/#pharmaceuticals
975,000 unit RecoveryRx Device Deal Signed
Synergy Corporation
Medical Devices
Headquartered in Singapore, SYNERGY is the leading growth partner for medical device companies in Africa, PAN India & South East Asia. Our experts provide customized Market Expansion Services that include marketing and sales, distribution, regulatory consulting and specialized services like consignment inventory management.
With our expert therapeutic knowledge and long-standing relationships, we provide unrivaled reach into various hospital environments, including operating theaters, day surgery clinics, outpatient surgery units, dental clinics and diagnostic laboratories. Our fast and efficient distribution service includes medical consumables, round-the-clock delivery of life-saving products, as well as after-sales services for capital expenditure equipment.
A compliant approach with all legal requirements ensures that the quality of the product is guaranteed throughout the value chain. Our areas of interest currently include ICU Solutions, Radiography, Radiotherapy as well as cardiological stents, pacemakers, implants etc.
https://synergy-corporation.com/our-business/
Nice Buy toohot, One Hour Until First BIEL Live Stockholder Meeting
Release #:812-239346-rl-1190694:
Topic: BioElectronics Stockholders Meeting
Time: Aug 25, 2022 11:00 AM Eastern Time (US and Canada)
Join the Zoom Meeting at
https://duke.zoom.us/j/92477451850?pwd=clhIdU1ZNDBjRERBZWo3MnZnM05zQT09
Meeting ID: 924 7745 1850
Passcode: Biel
Or call in at:
One tap mobile
+13017158592,,92477451850# US (Washington DC)
+13092053325,,92477451850# US
Or Dial by your location
+1 301 715 8592 US (Washington DC)
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 646 876 9923 US (New York)
+1 646 931 3860 US
+1 669 900 6833 US (San Jose)
+1 719 359 4580 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 386 347 5053 US
+1 408 638 0968 US (San Jose)
+1 564 217 2000 US
+1 669 444 9171 US
Meeting ID: 924 7745 1850
Find your local number: https://duke.zoom.us/u/acHdBaDZH2
Join by SIP
92477451850@zoomcrc.com
Join by H.323
162.255.37.11 (US West)
162.255.36.11 (US East)
115.114.131.7 (India Mumbai)
115.114.115.7 (India Hyderabad)
213.19.144.110 (Amsterdam Netherlands)
213.244.140.110 (Germany)
103.122.166.55 (Australia Sydney)
103.122.167.55 (Australia Melbourne)
149.137.40.110 (Singapore)
64.211.144.160 (Brazil)
149.137.68.253 (Mexico)
69.174.57.160 (Canada Toronto)
65.39.152.160 (Canada Vancouver)
207.226.132.110 (Japan Tokyo)
149.137.24.110 (Japan Osaka)
Meeting ID: 924 7745 1850
Passcode: 012041
Go BIEL !!!
Heads Up for BIEL Longs re Shareholders Call
IMO, Keith will be discussing several significant advances BIEL has made/is making in tomorrow's Call.
There is a possibility one of them could reach the level of a 'Material Event',
News or details that may reasonably be expected to affect a company’s stock price and thus decisions that investors make about buying or selling the company’s stock.
Since the Call is being held during Market Hours trading may be Halted for one hour if a Material Event is disclosed. This is standard FINRA protocol to give investors a chance to evaluate the news before trading.
I mention this so nobody panics if a Halt should occur or believes someone spinning a halt as doom for BIEL.
Exciting Times for BIEL !!
BIEL has 5 FDA Clearances that disagree with your Opinion.
I will go with the most knowledgeable medical regulatory agency in the world.
Everyone has already placed their Bets
Those who feel the 8/25 Shareholder's Call will not prove to be a positive event for BIEL have already sold.
Those who feel it will be a positive event have already established a position or added to their existing position.
Those who are on the fence between the two Opinions are still not buying or selling.
We find out who was correct in 40 hours.
I am not well versed in Zoom Pro, used it once several years ago and things went OK
I was also able to connect in a trial run & hope it functions on Thursday.
If not I will fall back to a call in connection.
42 hours to go !!
Wrong Again, Q3 2021 BIEL's First Profitable Quarter, many more to come
I suggest reading Financials once in a while.
<<<<<<<<<< This company never was or will be profitable >>>>>>>>>>
Q3 2021, $22,381 in profit
https://www.otcmarkets.com/otcapi/company/financial-report/311485/content
Q1 2022, $17,218 away from Profitability
https://www.otcmarkets.com/otcapi/company/financial-report/333292/content
No need to wait for the 25th plenty of "Lies" right here, right now
<<<<<<< real majority of share holders are skeptical about the 25th >>>>>>>
LOL, exactly how many shareholders were questioned on this subject?
I know, it was a 'Sales-trac' Poll, unburdened by Facts, just one person's Opinion.
While pitching a business, this former slugger found a hit
Washington Post
Value Added: While pitching a business, this former slugger found a hit
By Thomas Heath December 4, 2011
Business
When I think of ex-baseball players, I think of guys who are now high school coaches or minor league assistant managers or somebody who sits in a booth doing play-by-play for a small-town team.
The word “entrepreneur” doesn’t jump to mind.
But it applies to Keith Nalepka, 39, an ex-jock and Silver Spring native who smartly parlayed his baseball talent into a college degree and a set of life skills that brought him his own company.
The former high school slugger for Good Counsel (his batting average was a whopping .444) is an executive and part owner of a technology company called Hi-G-Tek — split between Rockville and Israel — that has a cool mission: It builds and installs postage-stamp-size electronic sensors that keep an eye on everything from nuclear materials to brain cancer drugs to gasoline.
If you bring a shipping container full of television sets into Ethiopia bound for a neighboring country, Nalepka’s sensors are going to know if someone opens the container five miles down the road and sells them on the black market. Hi-G-Tek’s client is the government of Ethiopia, which wants to collect duty on those televisions if they are sold inside the country.
If Barrick Gold, the giant Canadian mining company, wants to know whether someone is pilfering fuel from its house-size dump trucks, Hi-G-Tek sensors lets them know if a fuel valve has been opened.
And if the $2 million worth of an experimental brain cancer drug in a messenger’s case is tampered with, Nalepka’s company will know.
Same with nuclear material in hospital drawers, or a store of temperature-sensitive insulin.
“We keep an eye on high-value assets,” Nalepka said.
The company should break even this year on about $6 million in sales. Its diversified group of owners includes a radiologist friend of Nalepka’s named M.S. Kim, who owns the biggest share of the company, while Nalepka and two partners, founder Micha Auerbach of Israel and executive Elio Oliva, own the rest.
What intrigued me most about Nalepka and Hi-G-Tek, aside from serving a niche that I had never known existed, is Nalepka’s appetite for entrepreneurship and the smarts to use baseball to get there.
He may not have made “The Show,” as baseball’s major leagues are called, but it looks like he didn’t whiff on some big decisions.
One of the keys of success, I believe, is trying to put yourself in positions where opportunities arise and then making the most of them. You don’t have to get every decision right, but you have to hit some squarely.
Nalepka knew all along that getting a college degree was going to be key. When he signed with the Texas Rangers right out of high school in 1991, Nalepka banked his bonus and eventually put it toward his degree from Maryland. He lived during the baseball season on the $2,500-a-month paycheck he earned catching for the Rangers’ farm teams in Butte, Mont., and Port Charlotte, Fla. He went to school during the offseason.
He never made it to the majors and left after five years for a job, which friends helped him find, selling an asthma drug for Forest Pharmaceuticals on Long Island.
During his career selling pharmaceuticals, Nalepka tried to apply the same discipline. He harbored an itch to go into business for himself and he constantly pitched Kim, a family friend, on business ideas in and around the health field. But Kim kept passing.
In 2010, he began an entrepreneurial program at Johns Hopkins Carey Business School that taught him how to start and grow technology-based businesses.
“It wasn’t spending half a semester in accounting,” he said. “It was a hands-on program. I was learning how to pitch, how to raise money, how get small business grants.”
Opportunity struck when he was at a Johns Hopkins networking event about a year ago, pitching a group of investors and lawyers on a business built on guaranteeing the safe transportation of high-value drugs.
https://www.washingtonpost.com/business/economy/value-added-while-pitching-a-business-this-former-slugger-found-a-hit/2011/12/02/gIQAm8mcTO_story.html
I will point to a disclaimer that must be true, right?
"Everything I say and write is my opinion and my opinion only."
Time for another disclosure for any new visitors
There is no 'Sales-Trac' it is a fantasy company made up to spread Fake News.
BIEL's ActiPatch has a monopoly on PSWT Pain Relief FDA Cleared Over the Counter Medical Devices. Kind of hard to have "Too many other products beating BIEL too death" when you own the 'Pulsed ShortWave Therapy' market in the US.
510(k) Premarket Notification
1 to 2 of 2 Results
ProductCode: PQY Decision Date To: 08/22/2022
New Search
Actipatch BioElectronics Corporation K192234 01/31/2020
Actipatch(R) BIOELECTRONICS CORPORATION K152432 02/03/2017
Thanks toohot, ES RecoveryRx Needs to be Fast Tracked to Reduce Drug Use
That $650 million was for just 2 counties in Ohio. How many counties across the US?
Offering Non-Drug Pain Relief options to patients should be part of these Opioid settlements.